| Course | NUR-7641 Advanced Assessment, Differential Diagnosis, and Management of Psychiatric Disorders Child and Adolescent Populations, Part B |
|---|---|
| Module | Module 1 |
| Paper type | Case analysis: childhood ADHD |
| Length | About 1,120 words, 7 pages |
| Format | APA 7 student paper |
| School | Thomas Edison State University |
| Program | M.S. in Nursing, Psychiatric Mental Health Nurse Practitioner |
| Updated | October 2026 |
Free sample paper for NUR 7641 Module 1
Two Settings, Two Raters and One Titration Plan: Methylphenidate, a Daily Report Card and Parent Training for Marcus at Age Eight
Student Name
M.S. in Nursing, Psychiatric Mental Health Nurse Practitioner, Thomas Edison State University
NUR-7641: Advanced Assessment, Differential Diagnosis, and Management of Psychiatric Disorders: Child and Adolescent Populations, Part B
Mentor Name
Month Day, Year
Two Settings, Two Raters and One Titration Plan: Methylphenidate, a Daily Report Card and Parent Training for Marcus at Age Eight
A Teacher's Notes and a Three-Hour Homework Night
Marcus is an invented patient, 8 years old and in third grade at a public school in Trenton. According to his teacher, Marcus is out of his chair a dozen times in a lesson, shouts answers, loses worksheets and completes about half of his written work. At home his mother describes homework that stretches past bedtime, constant interrupting and a bicycle accident last spring when he rode into the street without looking. These problems began before kindergarten, according to his preschool reports, and have grown as school demands have grown. He is liked by classmates but has begun to be left out of games because he cannot wait his turn.
His medical history is unremarkable. He was born at term, met his milestones on time and has no history of seizures, fainting or chest pain with exercise. His father, who lives in Philadelphia, was told as a boy that he had attention problems but was never treated. Marcus sleeps about nine hours, snores only with colds and eats well.
Confirming the Diagnosis Across Settings
A diagnosis requires symptoms in more than one setting, so his mother and his teacher each completed a standardized ADHD rating scale. Both placed him well above the cutoff for combined presentation, with eight of nine hyperactive and impulsive items and seven of nine inattentive items endorsed by the teacher. The clinic interview with Marcus fit what the adults reported: he could not stay seated through a ten-minute conversation and answered questions before they were finished.
Other explanations were looked for before the label was given. His hearing and vision screens at school were normal. Loud snoring and daytime sleepiness, which can mimic inattention, were absent. A reading assessment arranged through his school found him at grade level, which makes a learning disorder unlikely as the main cause, although his written output lags. No recent move, loss or exposure to violence explains the change, and his mood is cheerful apart from frustration over schoolwork. Mild oppositional behavior at homework time is noted but falls short of a separate disorder.
What the MTA Trial Found
The Multimodal Treatment Study of Children With ADHD randomly assigned 579 children aged 7 to 9 to four groups for 14 months: carefully managed medication with monthly visits, intensive behavioral treatment for parent, school and child, the two combined, or usual care from community providers (MTA Cooperative Group, 1999). All groups improved, but for core ADHD symptoms the managed medication and combined groups did significantly better than behavioral treatment alone and community care. Combined treatment did not beat medication alone on core symptoms, yet it gave modest added gains in areas such as oppositional behavior, social skills, parent and child relations and reading.
One detail matters for Marcus's plan. Two thirds of the community care group also took medication, yet they did worse than the managed medication group. The difference lay in how the medicine was given: careful titration to the best dose, three daily doses and regular contact with teachers. That is the model the plan follows.
Choosing the Medicine
Cortese et al. (2018) combined results from 133 blinded trials to rank ADHD medicines against one another and against placebo across children, adolescents and adults. Taking side effects into account along with symptom relief, the authors judged methylphenidate the best opening drug for school-age patients and teenagers, and amphetamines the best for adults. Amphetamines worked at least as well in children but were less well tolerated in that age group. On this evidence Marcus starts a long-acting methylphenidate given once each morning, which avoids a dose at school and covers homework time.
Before the first dose, his weight, height, pulse and blood pressure are recorded, and the family and cardiac history is reviewed. With no fainting, chest pain, palpitations or early sudden death in relatives, no electrocardiogram is required.
| Step | Plan for Marcus |
|---|---|
| Start | Long-acting methylphenidate, lowest dose, each morning |
| Titration | Raise every week while teacher ratings improve and side effects allow |
| Monitoring | Weight, height, pulse and pressure at every visit |
| If appetite falls | Larger breakfast and evening snack, dose review |
| Second option | Guanfacine extended release, alone or added |
When a Stimulant Is Not Enough
Hirota et al. (2014) reviewed trials of the alpha-2 agonists guanfacine and clonidine for ADHD in young people. Used alone, they reduced overall symptoms, hyperactivity and inattention compared with placebo, and added to a stimulant they gave a smaller further benefit. The trade-off was more fatigue and sleepiness, along with lower blood pressure and a slower pulse. For Marcus, an alpha-2 agonist is the second step if methylphenidate cannot be raised far enough because of appetite loss, if afternoon rebound makes evenings hard, or if tics appear. His family is told about sleepiness and the need to taper rather than stop the medicine abruptly.
The Behavioral Half of the Plan
Medication alone will not teach Marcus how to finish homework or wait his turn. His mother joins an eight-session parent training group at the clinic that teaches specific praise, clear commands, planned ignoring of minor behavior and a reward chart with points he can trade for screen time on weekends. Homework is broken into short blocks with a timer and a break after each.
His teacher agrees to a daily report card with three goals: staying in his seat during independent work, raising his hand before speaking and handing in his worksheets. She circles yes or no for each goal and sends the card home, where points are added to his chart. If his written work stays far behind after medicine is adjusted, his mother is guided to request an evaluation for a Section 504 plan, which could give him extra time and a seat near the teacher.
Follow-Up
He is seen every week by phone or video during titration and in person at one month, when ratings from his teacher and mother are repeated. Weight is plotted on a growth chart each visit. After the dose is settled, visits move to every three months. His mother is asked to report any new tics, trouble falling asleep or low mood in the afternoon.
Conclusion
Marcus meets criteria for ADHD, combined presentation, on ratings from home and school, with other causes ruled out. The MTA trial supports carefully titrated medication as the core of his treatment, and the network meta-analysis supports methylphenidate as the first drug for a child his age. Parent training and a daily report card add the skills medicine cannot, and an alpha-2 agonist waits as the next step if side effects limit the stimulant.
References
Cortese, S., Adamo, N., Del Giovane, C., Mohr-Jensen, C., Hayes, A. J., Carucci, S., Atkinson, L. Z., Tessari, L., Banaschewski, T., Coghill, D., Hollis, C., Simonoff, E., Zuddas, A., Barbui, C., Purgato, M., Steinhausen, H. C., Shokraneh, F., Xia, J., & Cipriani, A. (2018). Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: A systematic review and network meta-analysis. The Lancet Psychiatry, 5(9), 727-738. https://doi.org/10.1016/S2215-0366(18)30269-4
Hirota, T., Schwartz, S., & Correll, C. U. (2014). Alpha-2 agonists for attention-deficit/hyperactivity disorder in youth: A systematic review and meta-analysis of monotherapy and add-on trials to stimulant therapy. Journal of the American Academy of Child and Adolescent Psychiatry, 53(2), 153-173. https://doi.org/10.1016/j.jaac.2013.11.009
MTA Cooperative Group. (1999). A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Archives of General Psychiatry, 56(12), 1073-1086. https://doi.org/10.1001/archpsyc.56.12.1073
What the NUR 7641 Module 1 instructions ask for
Part B of NUR-7641 asks students to apply prescriptive authority, symptom assessment and treatment with children and teenagers, and since TESU keeps the syllabus inside the course, this opening module takes the condition a pediatric psychiatric clinic sees most. Expect a case analysis that confirms ADHD from two settings, rules out medical and learning explanations, chooses a first medicine from trial evidence, writes titration and monitoring steps and adds a behavioral plan for home and school. Some sections give an adolescent or a preschool case instead, which changes the first medicine and the role of parent training. Check whether your directions want rating scale names and scores reported. Name the cardiac questions you asked before prescribing.
How this NUR 7641 Module 1 example is built
Marcus's teacher notes and his three-hour homework nights open the paper, followed by his medical and family history. Ratings from his mother and teacher confirm the combined presentation, and sleep, hearing and learning causes are ruled out. The MTA results set medication management as the core, with the lesson of the community care group. The network meta-analysis supports methylphenidate, and a five-row table lays out the titration plan. Alpha-2 agonists are named as the second step with their side effects. Parent training, a daily report card and a possible 504 plan form the behavioral half, and follow-up visits close the paper. Growth and vital signs are plotted from the first visit.
Where the marks sit in the NUR 7641 Module 1 rubric
ADHD cases are graded on a diagnosis supported by two settings, exclusion of other causes, a first medicine chosen from evidence, a clear titration schedule, cardiac screening and growth monitoring, and a behavioral plan that reaches the school. Mentors look for the reason one stimulant class was chosen for this age group. Plans that state what will happen if appetite or sleep suffers show judgment beyond the first prescription. Accurate reporting of the MTA results, including the community care finding, is often credited. School supports, such as a daily report card or a 504 plan, should be named, and trial results should be cited in APA style. Naming who reports side effects between visits, and how, adds strength.
NUR 7641 Module 1 help: mistakes that cost marks
Students often diagnose from a parent's account alone. Get the teacher's ratings into the case. Another gap is a prescription with no titration steps or vital signs; write both. Do not claim that combined treatment beat medicine for core symptoms, since the MTA trial found it did not. State the cardiac questions asked before a stimulant and the growth chart that follows it. Name the second medicine and the reason it would be needed. Give the school a concrete role. Send your own ADHD case and directions to the desk, and the first draft comes free of charge. Plot weight on a growth chart at every visit.
Write yours, or have the desk draft it
This paper is an original model document written by our desk, not a submitted student paper and not an official Thomas Edison State University document. Read it for the moves, then write your own to the instructions in your classroom. If you want one built to your exact prompt and rubric, the first custom sample is free and arrives in 24 to 48 hours.
More NUR 7641 and M.S. in Nursing, Psychiatric Mental Health Nurse Practitioner sample papers
- NUR 7641 Module 2: Childhood Anxiety Case: SCARED Screening, CBT and Sertraline
- NUR 7641 Module 3: Tourette Disorder Case: YGTSS Scoring, CBIT and When to Medicate
- NUR 7641 Module 4: Pediatric OCD Case: CY-BOCS, Exposure Therapy and an SSRI
- NUR 7641 Module 5: Adolescent Suicide Risk Case: ASQ Screening, Safety Planning and DBT
- NUR 7641 Module 6: Severe Irritability Case: DMDD, Bipolar Disorder and the Diagnostic Boundary
- NUR 7620 Module 1: Individual Therapy Case: CBT, Sertraline or Both for Moderate Depression
- NUR 7642 Module 2: Borderline Personality Disorder Case: DBT, General Psychiatric Management and Long-Term Course
- NUR 7631 Module 1: Adolescent Substance Use Case: CRAFFT Screening and Cannabis Use Disorder
- NUR 7633 Module 4: Late-Life Anxiety Case: Benzodiazepine Deprescribing, Beers Criteria and Escitalopram
NUR 7641 Module 1 questions, answered
Where can I find a free NUR 7641 Module 1 sample paper?
Marcus's ADHD case, from two sets of ratings to a titration plan and a daily report card, is printed in full above.
What did the MTA study find?
Carefully managed medication beat intensive behavioral treatment and community care for core ADHD symptoms over 14 months; adding behavioral treatment gave modest extra gains in other areas.
Which ADHD medicine is first choice for children?
A large network meta-analysis supports methylphenidate as the preferred first choice in children and adolescents, weighing benefit against tolerability.
When are guanfacine or clonidine used for ADHD?
When stimulants are not tolerated or not enough, or when tics or evening rebound are a problem; they cause more sleepiness and lower pulse and pressure.
Does a child need an ECG before starting a stimulant?
Not routinely; a careful cardiac and family history and baseline pulse and blood pressure come first, with an ECG when that history raises concern.